ArticleDiabetes & metabolic syndrome

Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery.

Mohammad Shafi Kuchay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.